Copyright Reports & Markets. All rights reserved.

Global In Vitro ADME-Tox Market Growth (Status and Outlook) 2021-2026

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global In Vitro ADME-Tox Market Size 2016-2026
    • 2.1.2 In Vitro ADME-Tox Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 In Vitro ADME-Tox Segment by Type
    • 2.2.1 Small Molecules
    • 2.2.2 Small Molecules
  • 2.3 In Vitro ADME-Tox Market Size by Type
    • 2.3.1 Global In Vitro ADME-Tox Market Size CAGR by Type
    • 2.3.2 Global In Vitro ADME-Tox Market Size Market Share by Type (2016-2021)
  • 2.4 In Vitro ADME-Tox Segment by End User
    • 2.4.1 Biopharmaceutical Companies
    • 2.4.2 Government and Academic Institutes
    • 2.4.3 Others
  • 2.5 In Vitro ADME-Tox Market Size by End User
    • 2.5.1 Global In Vitro ADME-Tox Market Size CAGR by End User
    • 2.5.2 Global In Vitro ADME-Tox Market Size Market Share by End User (2016-2021)

3 In Vitro ADME-Tox Market Size by Players

  • 3.1 In Vitro ADME-Tox Market Size Market Share by Players
    • 3.1.1 Global In Vitro ADME-Tox Revenue by Players (2019-2021E)
    • 3.1.2 Global In Vitro ADME-Tox Revenue Market Share by Players (2019-2021E)
  • 3.2 Global In Vitro ADME-Tox Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 In Vitro ADME-Tox by Regions

  • 4.1 In Vitro ADME-Tox Market Size by Regions (2016-2021)
  • 4.2 Americas In Vitro ADME-Tox Market Size Growth (2016-2021)
  • 4.3 APAC In Vitro ADME-Tox Market Size Growth (2016-2021)
  • 4.4 Europe In Vitro ADME-Tox Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa In Vitro ADME-Tox Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas In Vitro ADME-Tox Market Size by Country (2016-2021)
  • 5.2 Americas In Vitro ADME-Tox Market Size by Type (2016-2021)
  • 5.3 Americas In Vitro ADME-Tox Market Size by End User (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC In Vitro ADME-Tox Market Size by Region (2016-2021)
  • 6.2 APAC In Vitro ADME-Tox Market Size by Type (2016-2021)
  • 6.3 APAC In Vitro ADME-Tox Market Size by End User (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe In Vitro ADME-Tox by Country (2016-2021)
  • 7.2 Europe In Vitro ADME-Tox Market Size by Type (2016-2021)
  • 7.3 Europe In Vitro ADME-Tox Market Size by End User (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa In Vitro ADME-Tox by Region (2016-2021)
  • 8.2 Middle East & Africa In Vitro ADME-Tox Market Size by Type (2016-2021)
  • 8.3 Middle East & Africa In Vitro ADME-Tox Market Size by End User (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global In Vitro ADME-Tox Market Forecast

  • 10.1 Global In Vitro ADME-Tox Forecast by Regions (2021-2026)
    • 10.1.1 Global In Vitro ADME-Tox Forecast by Regions (2021-2026)
    • 10.1.2 Americas In Vitro ADME-Tox Forecast
    • 10.1.3 APAC In Vitro ADME-Tox Forecast
    • 10.1.4 Europe In Vitro ADME-Tox Forecast
    • 10.1.5 Middle East & Africa In Vitro ADME-Tox Forecast
  • 10.2 Americas In Vitro ADME-Tox Forecast by Countries (2021-2026)
    • 10.2.1 United States In Vitro ADME-Tox Market Forecast
    • 10.2.2 Canada In Vitro ADME-Tox Market Forecast
    • 10.2.3 Mexico In Vitro ADME-Tox Market Forecast
    • 10.2.4 Brazil In Vitro ADME-Tox Market Forecast
  • 10.3 APAC In Vitro ADME-Tox Forecast by Region (2021-2026)
    • 10.3.1 China In Vitro ADME-Tox Market Forecast
    • 10.3.2 Japan In Vitro ADME-Tox Market Forecast
    • 10.3.3 Korea In Vitro ADME-Tox Market Forecast
    • 10.3.4 Southeast Asia In Vitro ADME-Tox Market Forecast
    • 10.3.5 India In Vitro ADME-Tox Market Forecast
    • 10.3.6 Australia In Vitro ADME-Tox Market Forecast
  • 10.4 Europe In Vitro ADME-Tox Forecast by Country (2021-2026)
    • 10.4.1 Germany In Vitro ADME-Tox Market Forecast
    • 10.4.2 France In Vitro ADME-Tox Market Forecast
    • 10.4.3 UK In Vitro ADME-Tox Market Forecast
    • 10.4.4 Italy In Vitro ADME-Tox Market Forecast
    • 10.4.5 Russia In Vitro ADME-Tox Market Forecast
  • 10.5 Middle East & Africa In Vitro ADME-Tox Forecast by Region (2021-2026)
    • 10.5.1 Egypt In Vitro ADME-Tox Market Forecast
    • 10.5.2 South Africa In Vitro ADME-Tox Market Forecast
    • 10.5.3 Israel In Vitro ADME-Tox Market Forecast
    • 10.5.4 Turkey In Vitro ADME-Tox Market Forecast
    • 10.5.5 GCC Countries In Vitro ADME-Tox Market Forecast
  • 10.6 Global In Vitro ADME-Tox Forecast by Type (2021-2026)
  • 10.7 Global In Vitro ADME-Tox Forecast by End User (2021-2026)

11 Key Players Analysis

  • 11.1 Charles River
    • 11.1.1 Charles River Company Information
    • 11.1.2 Charles River In Vitro ADME-Tox Product Offered
    • 11.1.3 Charles River In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 Charles River Main Business Overview
    • 11.1.5 Charles River Latest Developments
  • 11.2 Labcorp
    • 11.2.1 Labcorp Company Information
    • 11.2.2 Labcorp In Vitro ADME-Tox Product Offered
    • 11.2.3 Labcorp In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 Labcorp Main Business Overview
    • 11.2.5 Labcorp Latest Developments
  • 11.3 Envigo
    • 11.3.1 Envigo Company Information
    • 11.3.2 Envigo In Vitro ADME-Tox Product Offered
    • 11.3.3 Envigo In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 Envigo Main Business Overview
    • 11.3.5 Envigo Latest Developments
  • 11.4 Curia
    • 11.4.1 Curia Company Information
    • 11.4.2 Curia In Vitro ADME-Tox Product Offered
    • 11.4.3 Curia In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 Curia Main Business Overview
    • 11.4.5 Curia Latest Developments
  • 11.5 Evotec
    • 11.5.1 Evotec Company Information
    • 11.5.2 Evotec In Vitro ADME-Tox Product Offered
    • 11.5.3 Evotec In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 Evotec Main Business Overview
    • 11.5.5 Evotec Latest Developments
  • 11.6 Bioduro-Sundia
    • 11.6.1 Bioduro-Sundia Company Information
    • 11.6.2 Bioduro-Sundia In Vitro ADME-Tox Product Offered
    • 11.6.3 Bioduro-Sundia In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 Bioduro-Sundia Main Business Overview
    • 11.6.5 Bioduro-Sundia Latest Developments
  • 11.7 Lonza
    • 11.7.1 Lonza Company Information
    • 11.7.2 Lonza In Vitro ADME-Tox Product Offered
    • 11.7.3 Lonza In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
    • 11.7.4 Lonza Main Business Overview
    • 11.7.5 Lonza Latest Developments
  • 11.8 WuXi AppTec
    • 11.8.1 WuXi AppTec Company Information
    • 11.8.2 WuXi AppTec In Vitro ADME-Tox Product Offered
    • 11.8.3 WuXi AppTec In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
    • 11.8.4 WuXi AppTec Main Business Overview
    • 11.8.5 WuXi AppTec Latest Developments
  • 11.9 IQVIA
    • 11.9.1 IQVIA Company Information
    • 11.9.2 IQVIA In Vitro ADME-Tox Product Offered
    • 11.9.3 IQVIA In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
    • 11.9.4 IQVIA Main Business Overview
    • 11.9.5 IQVIA Latest Developments
  • 11.10 Tecan Group
    • 11.10.1 Tecan Group Company Information
    • 11.10.2 Tecan Group In Vitro ADME-Tox Product Offered
    • 11.10.3 Tecan Group In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
    • 11.10.4 Tecan Group Main Business Overview
    • 11.10.5 Tecan Group Latest Developments

11. Pharmaron

  • 11.11.1 Pharmaron Company Information
  • 11.11.2 Pharmaron In Vitro ADME-Tox Product Offered
  • 11.11.3 Pharmaron In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
  • 11.11.4 Pharmaron Main Business Overview
  • 11.11.5 Pharmaron Latest Developments
  • 11.12 Shanghai Medicilon
    • 11.12.1 Shanghai Medicilon Company Information
    • 11.12.2 Shanghai Medicilon In Vitro ADME-Tox Product Offered
    • 11.12.3 Shanghai Medicilon In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
    • 11.12.4 Shanghai Medicilon Main Business Overview
    • 11.12.5 Shanghai Medicilon Latest Developments
  • 11.13 ChemPartner
    • 11.13.1 ChemPartner Company Information
    • 11.13.2 ChemPartner In Vitro ADME-Tox Product Offered
    • 11.13.3 ChemPartner In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
    • 11.13.4 ChemPartner Main Business Overview
    • 11.13.5 ChemPartner Latest Developments
  • 11.14 Joinn Laboratories
    • 11.14.1 Joinn Laboratories Company Information
    • 11.14.2 Joinn Laboratories In Vitro ADME-Tox Product Offered
    • 11.14.3 Joinn Laboratories In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
    • 11.14.4 Joinn Laboratories Main Business Overview
    • 11.14.5 Joinn Laboratories Latest Developments
  • 11.15 RTI International
    • 11.15.1 RTI International Company Information

    • According to this latest study, the 2021 growth of In Vitro ADME-Tox will have significant change from previous year. By the most conservative estimates of global In Vitro ADME-Tox market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the In Vitro ADME-Tox market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

    This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro ADME-Tox market by product type, application, key players and key regions and countries.

    Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
    Small Molecules
    Biologics

    Segmentation by end user: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
    Biopharmaceutical Companies
    Government and Academic Institutes
    Others

    This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    Charles River
    Labcorp
    Envigo
    Curia
    Evotec
    Bioduro-Sundia
    Lonza
    WuXi AppTec
    IQVIA
    Tecan Group
    Pharmaron
    Shanghai Medicilon
    ChemPartner
    Joinn Laboratories
    RTI International
    Eurofins Scientific
    Aragen Life Sciences
    Sai Life Sciences
    Buy now